Lisa Ng
#90,289
Most Influential Person Now
Viral immunologist
Lisa Ng's AcademicInfluence.com Rankings
Lisa Ngbiology Degrees
Biology
#6010
World Rank
#8624
Historical Rank
Immunology
#539
World Rank
#556
Historical Rank
Download Badge
Biology
Lisa Ng's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Immunology Stanford University
Similar Degrees You Can Earn
Why Is Lisa Ng Influential?
(Suggest an Edit or Addition)According to Wikipedia, Lisa Ng is a Singaporean viral immunologist. In 2008, she became the first Singaporean and the first woman to win the ASEAN Young Scientist and Technologist Award for her work in developing diagnostic kits for Avian Influenza and Sars-CoV. She has been featured as part of the "Beyond Curie" project as a pioneer in viral immunology, as well as being inducted into the Singapore Women's Hall of Fame. Her ongoing research includes endemic tropical diseases and Sars-CoV-19.
Lisa Ng's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The trinity of COVID-19: immunity, inflammation and intervention (2020) (3182)
- Immunity, endothelial injury and complement-induced coagulopathy in COVID-19 (2020) (384)
- Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study (2020) (356)
- Persistent Arthralgia Induced by Chikungunya Virus Infection is Associated with Interleukin-6 and Granulocyte Macrophage Colony-Stimulating Factor (2011) (329)
- Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients (2020) (311)
- IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity (2009) (276)
- Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. (2017) (269)
- Active Infection of Human Blood Monocytes by Chikungunya Virus Triggers an Innate Immune Response (2010) (257)
- Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study (2021) (256)
- Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control (2020) (216)
- Catching bird flu in a droplet (2007) (213)
- A Pathogenic Role for CD4+ T Cells during Chikungunya Virus Infection in Mice (2013) (189)
- Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein (2012) (178)
- Viperin restricts chikungunya virus replication and pathology. (2012) (170)
- A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection (2020) (162)
- Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical Protection (2012) (161)
- Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In Vitro (2009) (148)
- An Essential Role of Antibodies in the Control of Chikungunya Virus Infection (2013) (142)
- Re-emergence of Chikungunya virus in South-east Asia: virological evidence from Sri Lanka and Singapore. (2010) (133)
- Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection (2018) (129)
- Viral dynamics and immune correlates of COVID-19 disease severity (2020) (126)
- Human genetic and immunological determinants of critical COVID-19 pneumonia (2022) (126)
- Longitudinal Analysis of the Human Antibody Response to Chikungunya Virus Infection: Implications for Serodiagnosis and Vaccine Development (2012) (121)
- Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19 (2020) (118)
- Zika Virus Infects Human Fetal Brain Microglia and Induces Inflammation (2017) (114)
- Chikungunya: a bending reality. (2009) (102)
- Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity (2020) (96)
- Identification of a Novel Cleavage Activity of the First Papain-Like Proteinase Domain Encoded by Open Reading Frame 1a of the Coronavirus Avian Infectious Bronchitis Virus and Characterization of the Cleavage Products (2000) (95)
- Chikungunya Virus Neutralization Antigens and Direct Cell-to-Cell Transmission Are Revealed by Human Antibody-Escape Mutants (2011) (94)
- Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network. (2017) (93)
- Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology (2015) (93)
- Immuno-biology of Chikungunya and implications for disease intervention. (2009) (93)
- The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling (2016) (91)
- A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection (2015) (90)
- Chikungunya Virus Envelope-Specific Human Monoclonal Antibodies with Broad Neutralization Potency (2011) (85)
- A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection (2004) (83)
- COVID-19 vaccines and kidney disease (2021) (81)
- Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation (2020) (79)
- Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response (2014) (77)
- Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections (2017) (74)
- SVM-based prediction of linear B-cell epitopes using Bayes Feature Extraction (2010) (74)
- Specific Biomarkers Associated With Neurological Complications and Congenital Central Nervous System Abnormalities From Zika Virus–Infected Patients in Brazil (2017) (67)
- Prime-Boost Immunization Strategies against Chikungunya Virus (2014) (67)
- Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation (2017) (67)
- Cerebral malaria (2012) (65)
- Monkeypox: disease epidemiology, host immunity and clinical interventions (2022) (64)
- Sero-Prevalence and Cross-Reactivity of Chikungunya Virus Specific Anti-E2EP3 Antibodies in Arbovirus-Infected Patients (2015) (63)
- Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19 (2020) (63)
- Cellular and molecular mechanisms of chikungunya pathogenesis. (2015) (62)
- Chikungunya virus pathogenesis and immunity. (2015) (61)
- The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study (2020) (57)
- Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity (2017) (56)
- Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay (2006) (55)
- Host Heterogeneous Ribonucleoprotein K (hnRNP K) as a Potential Target to Suppress Hepatitis B Virus Replication (2005) (54)
- Fingolimod treatment abrogates chikungunya virus–induced arthralgia (2017) (52)
- Detection of Severe Acute Respiratory Syndrome Coronavirus in Blood of Infected Patients (2004) (52)
- Further Characterization of the Coronavirus Infectious Bronchitis Virus 3C-like Proteinase and Determination of a New Cleavage Site (2000) (50)
- Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients (2021) (50)
- Epitope-Functionalized Gold Nanoparticles for Rapid and Selective Detection of SARS-CoV-2 IgG Antibodies (2021) (49)
- Therapeutics and vaccines against chikungunya virus. (2015) (47)
- Severity of Plasma Leakage Is Associated With High Levels of Interferon &ggr;–Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection (2017) (47)
- Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology (2012) (46)
- Immunopathogenesis and Virus–Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease (2017) (45)
- Expanding Regulatory T Cells Alleviates Chikungunya Virus-Induced Pathology in Mice (2015) (44)
- Identification of a 24-kDa Polypeptide Processed from the Coronavirus Infectious Bronchitis Virus 1a Polyprotein by the 3C-like Proteinase and Determination of Its Cleavage Sites (1998) (43)
- Persistence of Zika virus in conjunctival fluid of convalescence patients (2017) (43)
- SARS Transmission Pattern in Singapore Reassessed by Viral Sequence Variation Analysis (2005) (42)
- Nonstructural Proteins of Alphavirus—Potential Targets for Drug Development (2018) (42)
- Unique Epitopes Recognized by Antibodies Induced in Chikungunya Virus-Infected Non-Human Primates: Implications for the Study of Immunopathology and Vaccine Development (2014) (42)
- Comparative analysis of the genome sequences and replication profiles of chikungunya virus isolates within the East, Central and South African (ECSA) lineage (2013) (40)
- Chikungunya virus nsP4 RNA‐dependent RNA polymerase core domain displays detergent‐sensitive primer extension and terminal adenylyltransferase activities (2017) (40)
- Studying severe long COVID to understand post-infectious disorders beyond COVID-19 (2022) (40)
- Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection. (2013) (39)
- Longitudinal Study of Cellular and Systemic Cytokine Signatures to Define the Dynamics of a Balanced Immune Environment During Disease Manifestation in Zika Virus–Infected Patients (2018) (37)
- Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein (2020) (36)
- Rapid detection of viral RNA by a pocket-size real-time PCR system. (2010) (35)
- Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19 (2021) (34)
- Zika Virus Infection Preferentially Counterbalances Human Peripheral Monocyte and/or NK Cell Activity (2017) (34)
- Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity (2018) (34)
- An Integrated Lab-on-Chip for Rapid Identification and Simultaneous Differentiation of Tropical Pathogens (2014) (34)
- Membrane Association and Dimerization of a Cysteine-Rich, 16-Kilodalton Polypeptide Released from the C-Terminal Region of the Coronavirus Infectious Bronchitis Virus 1a Polyprotein (2002) (33)
- Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection (2020) (33)
- Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism (2020) (33)
- Coronaviruses in animals and humans (2020) (31)
- Trisubstituted Thieno[3,2-b]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses. (2015) (30)
- Zika virus: from an obscurity to a priority. (2018) (29)
- Early clearance of Chikungunya virus in children is associated with a strong innate immune response (2016) (29)
- Immunopathology of Chikungunya Virus Infection: Lessons Learned from Patients and Animal Models. (2017) (29)
- Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia (2022) (29)
- Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut (2017) (28)
- Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation (2015) (28)
- Structural Optimizations of Thieno[3,2-b]pyrrole Derivatives for the Development of Metabolically Stable Inhibitors of Chikungunya Virus. (2017) (27)
- Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19 (2020) (27)
- Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2 (2021) (26)
- GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics. (2019) (26)
- Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice (2018) (26)
- Zika Virus and the Eye (2018) (25)
- Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection (2022) (24)
- Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population (2017) (24)
- Plasmodium co-infection protects against chikungunya virus-induced pathologies (2018) (24)
- Clinical features of patients with Zika and dengue virus co-infection in Singapore. (2017) (23)
- Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians (2021) (23)
- A Sensitive Method for Detecting Zika Virus Antigen in Patients’ Whole-Blood Specimens as an Alternative Diagnostic Approach (2017) (22)
- Protein kinases C as potential host targets for the inhibition of chikungunya virus replication (2017) (22)
- Structural Studies of Chikungunya Virus-Like Particles Complexed with Human Antibodies: Neutralization and Cell-to-Cell Transmission (2015) (22)
- Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells (2015) (21)
- Immunological observations and transcriptomic analysis of trimester‐specific full‐term placentas from three Zika virus‐infected women (2019) (20)
- Neutrophils: neglected players in viral diseases. (2013) (20)
- Viperin controls chikungunya virus–specific pathogenic T cell IFNγ Th1 stimulation in mice (2019) (19)
- Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early prognostic marker for severe COVID-19 (2020) (19)
- Co‐infection with Chikungunya virus alters trafficking of pathogenic CD8+ T cells into the brain and prevents Plasmodium‐induced neuropathology (2017) (18)
- Immunological and Viral Correlates of COVID-19 Disease Severity: A Prospective Cohort Study of the First 100 Patients in Singapore (2020) (18)
- Chikungunya fever--re-emergence of an old disease. (2009) (18)
- Mosquito Saliva Reshapes Alphavirus Infection and Immunopathogenesis (2018) (18)
- Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs (2022) (18)
- Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs (2022) (18)
- HLA Class I Restriction as a Possible Driving Force for Chikungunya Evolution (2010) (17)
- Efficient detection of Zika virus RNA in patients’ blood from the 2016 outbreak in Campinas, Brazil (2018) (17)
- Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells (2021) (17)
- Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant (2021) (17)
- Clustering HLA Class I Superfamilies Using Structural Interaction Patterns (2014) (17)
- Systematic analysis of disease‐specific immunological signatures in patients with febrile illness from Saudi Arabia (2020) (16)
- Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate (2019) (16)
- Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study (2021) (16)
- Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease (2020) (16)
- Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial (2022) (16)
- A compendium of small molecule direct-acting and host-targeting inhibitors as therapies against alphaviruses (2017) (16)
- Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones. (2018) (15)
- GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 5: Entomological aspects. (2019) (15)
- Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019 (2020) (15)
- Chikungunya virus drug discovery: still a long way to go? (2019) (15)
- MIF receptor CD74 mediates alphavirus-induced arthritis and myositis: Requirement for CD74 in Alphavirus Arthritis and Myositis (2013) (14)
- Limitations of Current in Vivo Mouse Models for the Study of Chikungunya Virus Pathogenesis (2015) (13)
- Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore (2021) (13)
- Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients (2019) (13)
- Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection (2021) (13)
- VCP/p97 Is a Proviral Host Factor for Replication of Chikungunya Virus and Other Alphaviruses (2019) (12)
- Interferon regulatory factor 1 is essential for pathogenic CD8+ T cell migration and retention in the brain during experimental cerebral malaria (2018) (12)
- Virus infection drives IL-2 antibody complexes into pro-inflammatory agonists in mice (2016) (12)
- Occurrence of 4 Dengue Virus Serotypes and Chikungunya Virus in Kilombero Valley, Tanzania, During the Dengue Outbreak in 2018 (2020) (11)
- From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio (2021) (11)
- Comparison of the clinical features, viral shedding and immune response in vaccine breakthrough infection by the Omicron and Delta variants (2022) (11)
- Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose (2022) (11)
- Host response to Chikungunya virus and perspectives for immune-based therapies (2011) (10)
- A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients (2021) (10)
- Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care (2021) (10)
- ZIKV-Specific NS1 Epitopes as Serological Markers of Acute Zika Virus Infection. (2019) (9)
- Reply to Noret et al (2012) (9)
- Gas6 drives Zika virus-induced neurological complications in humans and congenital syndrome in immunocompetent mice (2021) (9)
- Neutralizing antibodies from early cases of SARS-CoV-2 infection offer cross-protection against the SARS-CoV-2 D614G variant (2020) (9)
- Fast Tracks and Roadblocks for Zika Vaccines (2018) (9)
- The 2016 Singapore Zika virus outbreak did not cause a surge in Guillain‐Barré syndrome (2018) (9)
- Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals (2022) (8)
- 14 – Arbovirus Infections (2014) (8)
- Pathogenic Th1 responses in CHIKV‐induced inflammation and their modulation upon Plasmodium parasites co‐infection (2019) (8)
- Age has a role in driving host immunopathological response to alphavirus infection (2017) (8)
- Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity (2020) (8)
- A sensitive epitope-blocking ELISA for the detection of Chikungunya virus-specific antibodies in patients. (2015) (7)
- TREM-1 activation is a potential key regulator in driving severe pathogenesis of enterovirus A71 infection (2020) (7)
- A cell-based system for hepatitis B virus replication: significance of clinically enhanced viral replication in relation to deletions in viral core promoter. (2005) (7)
- Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore (2021) (7)
- Cellular transcription modulator SMARCE1 binds to HBV core promoter containing naturally occurring deletions and represses viral replication. (2007) (7)
- Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals (2021) (6)
- Viperin Poisons Viral Replication. (2018) (6)
- Type I interferon shapes the quantity and quality of the anti‐Zika virus antibody response (2020) (6)
- Further identification and characterization of products processed from the coronavirus avian infectious bronchitis virus (IBV) 1a polyprotein by the 3C-like proteinase. (2001) (6)
- Sensitive Detection of Total Anti-Spike Antibodies and Isotype Switching in Asymptomatic and Symptomatic COVID-19 Patients (2020) (6)
- Chikungunya: international focus issue. (2015) (6)
- In silico prediction of the granzyme B degradome (2011) (6)
- Investigating the Cellular Transcriptomic Response Induced by the Makona Variant of Ebola Virus in Differentiated THP-1 Cells (2019) (5)
- Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape (2021) (4)
- Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection (2020) (4)
- Malaria abrogates O’nyong–nyong virus pathologies by restricting virus infection in nonimmune cells (2022) (4)
- COVID-19 and beyond: a call for action and audacious solidarity to all the citizens and nations, it is humanity’s fight (2020) (4)
- Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir (2021) (4)
- Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity (2022) (4)
- Durable T cell responses contrast with faster antibody waning in BNT162b2-vaccinated elderly at 6 month (2021) (3)
- Understanding infectious agents from an in silico perspective (2010) (3)
- Further characterisation of the coronavirus IBV ORF 1a products encoded by the 3C-like proteinase domain and the flanking regions. (1998) (3)
- Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
- Understanding Molecular Pathogenesis with Chikungunya Virus Research Tools. (2019) (3)
- Major advances against a moving target of CNS infections (2015) (3)
- The fine line between protection and pathology in neurotropic flavivirus and alphavirus infections (2014) (3)
- Multimodal assessments of Zika virus immune pathophysiological responses in marmosets (2018) (3)
- Myeloid cell Arg1 and iNOS inhibit control of arthritogenic alphavirus infection by suppressing anti-viral T cells (VIR1P.965) (2014) (2)
- Immune and pathophysiologic profiling of antenatal coronavirus disease 2019 in the GIFT cohort: A Singaporean case-control study (2022) (2)
- Immunoinformatics: how in silico methods are re-shaping the investigation of peptide immune specificity. (2012) (2)
- Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis (2022) (2)
- Novel differential linear B‐cell epitopes to identify Zika and dengue virus infections in patients (2020) (1)
- Comparative analysis of the genome sequences and replication profiles of chikungunya virus isolates within the East, Central and South African (ECSA) lineage (2013) (1)
- Host Response and Mechanisms of Subversion of Chikungunya (2016) (1)
- Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections (2022) (1)
- A promiscuous interaction of SARS-CoV-2 with bacterial products (2020) (1)
- Defining factors that influence vaccine-induced, cross-variant neutralizing antibodies for SARS-CoV-2 in Asians (2022) (1)
- Rapid microfluidic platform for screening and enrichment of cells secreting virus neutralizing antibodies. (2022) (1)
- Structural Studies of Chikungunya Virus-like Particles (2015) (1)
- Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care (2021) (1)
- Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine (2022) (1)
- Author Correction: Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity (2021) (1)
- Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease (2020) (1)
- The virus that changed my world. (2003) (1)
- Potency Neutralization Monoclonal Antibodies with Broad Chikungunya Virus Envelope-Specific Human (2011) (0)
- Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology (2012) (0)
- Immune Landscape of 382-Nt Deleted SARS-CoV-2 Reveals Heightened Adaptive Response Indicating Prophylactic Potential Against COVID-19 (2020) (0)
- THANKS TO OUR SPONSORS AND SUPPORTERS (0)
- Amorces de diagnostic et procede de detection des sous-types h5 et h5n1 du virus de la grippe aviaire (2005) (0)
- Efficient detection of Zika virus RNA in patients’ blood from the 2016 outbreak in Campinas, Brazil (2018) (0)
- Multimodal assessments of Zika virus immune pathophysiological responses in marmosets (2018) (0)
- et al. (2021). Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care. Genome Medicine, 13(5 (2021)), [5]. (2021) (0)
- Critical Capability Needs for Reduction of Transmission of SARS-CoV-2 Indoors (2021) (0)
- Title Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever : Association with Plasma Leakage and Disease Severity (2019) (0)
- Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant (2023) (0)
- COVID-19 and beyond: a call for action and audacious solidarity to all the citizens and nations, it is humanity’s fight [version 1; peer review: 3 approved with reservations] (2021) (0)
- The trinity of COVID-19: immunity, inflammation and intervention (2020) (0)
- PALM-SIZED REAL-TIME RT-PCR SYSTEM (2008) (0)
- Title Novel differential linear Bcell epitopes to identify Zika anddengue virus infections in patients (2019) (0)
- COVID-19 and beyond: a call for action and audacious solidarity to all the citizens and nations, it is humanity’s fight [version 1; peer review: awaiting peer review] (2020) (0)
- Positive‐strand RNA viruses—a Keystone Symposia report (2023) (0)
- Title Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro (2009) (0)
- Neutralization Potency Human Monoclonal Antibodies with Broad Chikungunya Virus Envelope-Specific (2011) (0)
- Persistence of Zika virus in conjunctival fluid of convalescence patients (2017) (0)
- Discrepant serological findings in SARS‐CoV‐2 PCR‐negative hospitalized patients with fever and acute respiratory symptoms during the pandemic (2022) (0)
- A Tool to Model Virus Particle Exposure in Residences (ViPER) (2022) (0)
- Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters (2022) (0)
- Immune Response by Chikungunya Virus Triggers an Innate Active Infection of Human Blood Monocytes (2010) (0)
- Trimester-specific Zika virus infection affects placental responses in women (2019) (0)
- Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity (2018) (0)
- Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection (2021) (0)
- Dynamic Alterations of Anti-S-Protein Igg Subclasses and of Th1/Th2 Responses are Hallmarks of Acute Severe COVID-19 Disease (2021) (0)
- Case Study: Chikungunya Virus (2016) (0)
- Chikungunya fever (2023) (0)
- Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection (2021) (0)
- Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC] (2022) (0)
- Mosquito saliva re-shapes alphavirus infection and 1 immunopathogenesis 2 (2018) (0)
- Plasmodium co-infection protects against chikungunya virus-induced pathologies (2018) (0)
- B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain (2023) (0)
- Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation (2017) (0)
- Immune and pathophysiologic profiling of antenatal COVID-19 in the GIFT cohort: A Singaporean case-control study. (2022) (0)
- CD8+ T-cells trigger auricular dermatitis and blepharitis in mice post-Zika virus infection in the absence of CD4+ T-cells. (2022) (0)
- COVID-19 and Beyond: A Call for Action and Audacious Solidarity to All the Citizens and Nations, It Is Humanity’s Fight (2020) (0)
- Organ‐specific immune response in lethal SARS‐CoV‐2 infection by deep spatial phenotyping (2022) (0)
- Myeloperoxidase inhibition may protect against endothelial glycocalyx shedding induced by COVID-19 plasma. (2023) (0)
- SARS-CoV-2 Infection Generates Long-Lived Memory B Cells Against the Receptor Binding Domain of the Spike Protein (2021) (0)
- Triggers an Innate Immune Response Monocytes by Chikungunya Virus Active Infection of Human Blood (2010) (0)
- Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients (2020) (0)
- Immunological observations and transcriptomic analysis of trimester-specific full-term placentas from three Zika virus-infected women. (2019) (0)
- Occurrence of Four Dengue Virus Serotypes and Chikungunya Virus in Kilombero, Tanzania during Dengue Outbreak in 2018 (2020) (0)
- TREM-1 activation is a key regulator in driving severe pathogenesis of enterovirus 71 infection (2019) (0)
- TREM-1 activation is a potential key regulator in driving severe pathogenesis of enterovirus A71 infection (2020) (0)
- Prolonged Inflammation in COVID-19 Survivors Resolves 2 Years After Coronavirus Disease 2019 (COVID-19) (2022) (0)
- Severity of plasma leakage is associated with high levels of IP-10 , HGF , MMP-2 and MMP-9 during dengue infections (2016) (0)
- Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection (2021) (0)
- Control of Chikungunya Virus Infection An Essential Role of Antibodies in the (2013) (0)
- Type I Interferon Shapes the Quantity and Quality of the Anti-Zika Virus Antibody Response (2019) (0)
- Data-driven analysis of COVID-19 reveals specific severity patterns distinct from the temporal immune response (2021) (0)
This paper list is powered by the following services:
Other Resources About Lisa Ng
What Schools Are Affiliated With Lisa Ng?
Lisa Ng is affiliated with the following schools:
